New possibilities for diabetic peripheral neuropathy treatment


Дәйексөз келтіру

Толық мәтін

Аннотация

Diabetic peripheral neuropathy (DPN) is frequent and prognostically important complication of diabetes mellitus. Modern diabetology pay great attention to the issues of early treatment of DPN. The data for risk factors, prognosis, pathogenesis, clinical presentation and the principles of diagnosis of DPN are presented. It is emphasized that therapeutic and preventive measures in DPN should begin as early as possible and should be carried out against the background of carbohydrate metabolism compensation. We consider the modern treatment of DPN with the use of pathogenetic and symptomatic therapy. Clinical data supporting the efficacy of the drug Actovegin in patients with DPN are presented.

Авторлар туралы

E Komelyagina

M Antsiferov

E Komelyagina

M Antsiferov

Әдебиет тізімі

  1. International guidelines on the out-patient management of diabetic peripheral neuropathy, 1996.
  2. Sima AAF, Thomas PK, Ishii D, et al. Diabetic neuropathies. Diabetologia 1997;40:74-7.
  3. Shaw JE, Zimmet PZ, Gries FA, et al. Epidemiology of Diabetic Neuropathy. In: Gries FA, Cameron NE, Low PA, Ziegler D (Eds.). Textbook of diabetic neuropathy. 2003;64-82.
  4. Ziegler D, Rathmann W, et al. Prevalence of Polyneuropathy in Prediabetes and Diabetes is Associated with Abdominal Obesity and Macroangiopathy. The MONICA/KORA Augsburg Surveys S2 and S3. Diabetes Care 2008;31:464-9.
  5. Daosi C, Bendow SJ, Woodward A, et al. The natural history of chronic painful peripheral neuropathy in a community diabetes population. DiabetMed 2006;23:1021-4.
  6. Davies M, Brophy S, Williams R, et al. The prevalence, severity, and impact of painful diabetic peripheral neuropathy in type 2 diabetes. Diabetes Care 2006;29:1518-22.
  7. Galer BS, Gianas A, Jensen MP. Painful diabetic neuropathy: epidemiology, pain description, and quality of life. Diabetes Res Clin Pract 2000;47:123-8.
  8. Partanen J, Niskanen L, et al. Natural history of peripheral neuropathy in patients in patients with non-insulin-dependent diabetes mellitus. N Engl J Med 1995;333:89-94.
  9. Cabezas-Cerrato J. The prevalence of clinical diabetic polyneuropathy in Spain: a study in primary care and hospital clinic groups. Neuropathy Spanish Study Group of the Spanish Diabetic Society (SDS). Diabetologia 1998;41:1263-9.
  10. Forsblom CM, Sane T, et al. Risk factors for mortality in type II (non-insulin-dependent) diabetes: evidence of a role for neuropathy and a protective effect of HLA-DR. Diabetologia 1998;41:1253-62.
  11. Navarro X, Kennedy WR, et al. Neuropathy and mortality in diabetes: influence of pancreas transplantation. Muscle Nerve 1996;19:1009-16.
  12. Boyko EJ, Ahroni JH, et al. Increased mortality associated with diabetic foot ulcers. Diabetic Med 1996;13:967-72.
  13. Циглер Дан. Диабетическая периферическая нейропатия: клинические проявления, диагностика и лечение. М., 2009.
  14. Thomas PK. Mechanisms of neuropathic pain. In: Textbook of Diabetic Neuropathy, Thieme 2002;208.
  15. Brown MJ, Martin JR. Painful diabetic neuropathy: a morphometric study. Arch Neurol 1976;33:164-71.
  16. Asbury AK, Fields HL. Pain due to peripheral nerve damage: an hypothesis. Neurology 1984;34:1587-90.
  17. Proceedings of a consensus development conference on standardized measures in diabetic neuropathy. Diabetes Care 1992;15(8):1080-1107.
  18. Lauria G, Cornblath DR, Johansson O, et al. European Federation of Neurological Societies. EFNS guidelines on the use of skin biopsy in the diagnosis of peripheral neuropathy. Eur J Neurol 2005;12:747-58.
  19. Bril V. Electrophysiologic testing. In: Textbook of Diabetic Neuropathy, Thieme 2002;177-84.
  20. The Diabetes Control and Complication Trial Research Group. The effect of intensive diabetes therapy on the development and progression of diabetic neuropathy. Ann Intern Med 1995;122:561-8.
  21. Spruce MC, Potter DV, et al. The pathogenesis and management of painful diabetic neuropathy: a review. Diabetic Med 2003;20(2):88-99.
  22. Ziegler D. Treatment of neuropathic pain. In: Textbook of Diabetic Neuropathy, Thieme 2002;211-24.
  23. Dworkin RH, O'Connor AB, et al. Pharmacologic management of neuropathic pain: evidence-based recommendations. Pain 2007;132:237-51
  24. Boulton AJM, Vinik AI, et al. Diabetic neuropathies: a statement by the American Diabetes Association. Diabetes Care 2005;28:956-62
  25. Машковский М.Д. Лекарственные средства. Пособие для врачей. М., 2005.724.
  26. Jensen W, Beck E. Treatment of the diabetic polyneuropathy. A controlled double blind study. Med Welt 1987;38:838-41.
  27. Zigler D, Movsesyan L. et al. Treatment of Symptomatic Polyneuropathy With Actovegin in Type 2 Diabetic Patients. Diabetes Care 2009;32(8):1479-84.

Қосымша файлдар

Қосымша файлдар
Әрекет
1. JATS XML
Жүктеу

© Bionika Media, 2010

Осы сайт cookie-файлдарды пайдаланады

Біздің сайтты пайдалануды жалғастыра отырып, сіз сайттың дұрыс жұмыс істеуін қамтамасыз ететін cookie файлдарын өңдеуге келісім бересіз.< / br>< / br>cookie файлдары туралы< / a>